Ambrx Biopharma Cayman, Inc. Unrecognized Tax Benefits USD 2019 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Unrecognized Tax Benefits history and growth rate from 2019 to 2022.
  • Ambrx Biopharma Cayman, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2022 was $4.73 M, a 70.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $4.73 M +$1.96 M +70.8% Dec 31, 2022 10-K 2023-03-30
Q4 2021 $2.77 M +$485 K +21.3% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $2.28 M +$309 K +15.7% Dec 31, 2020 10-K 2023-03-30
Q4 2019 $1.97 M Dec 31, 2019 20-F 2022-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.